Eileen E. Reynolds
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eileen E. Reynolds has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Howard Libman
Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts (H.L., M.T.L., B.L.R., E.E.R.).
5 shared publications- Zahir Kanjee
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts (H.L., Z.K.)
5 shared publications James Heffernan
Section of Primary Care, Division of General Medicine, BIDMC, Boston, USA
2 shared publications- Amy R. Weinstein
Harvard Medical School
1 shared publication Anjala Tess
Beth Israel Deaconess Medical Center, Boston, Massachusetts (E.E.R., M.K.B., B.L.S., A.T.).
1 shared publicationAri Moskowitz
Montefiore Medical Center, Bronx, New York (A.M.).
1 shared publication
Latest Publications
- 1 December 2025
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 178 (12) , 1785-1792
How Would You Manage This Diabetic Patient With a Foot Infection? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Foot infections are the most common cause of hospitalization in patients with diabetes. They may be superficial, involving only the skin, or deep, involving the soft tissues or bone. Superficial infections are generally caused by aerobic gram-positive cocci, whereas deep infections, including osteomyelitis, tend to be polymicrobial in origin. Clinical manifestations of skin and soft tissue infections include local evidence of inflammation, but peripheral neuropathy and peripheral artery disease may mask these findings. Management is determined by the extent of infection and often includes oral or parenteral antibiotic therapy in combination with surgical debridement. In 2023, the International Working Group on the Diabetic Foot and the Infectious Diseases Society of America updated their guideline on the diagnosis and management of diabetic foot infection. The guideline includes specific recommendations regarding the use of inflammatory markers, tissue and bone culture, and imaging studies in the diagnosis of diabetic foot infection, as well as the indications for surgical debridement and hospitalization. Here, 2 experts in this field, an infectious diseases physician and a podiatrist, debate how to manage the case of a diabetic patient with foot infection. They discuss diagnostic and treatment challenges in the care of this population.
- 1 December 2025
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 178 (12) , 1785-1792
How Would You Manage This Diabetic Patient With a Foot Infection? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Foot infections are the most common cause of hospitalization in patients with diabetes. They may be superficial, involving only the skin, or deep, involving the soft tissues or bone. Superficial infections are generally caused by aerobic gram-positive cocci, whereas deep infections, including osteomyelitis, tend to be polymicrobial in origin. Clinical manifestations of skin and soft tissue infections include local evidence of inflammation, but peripheral neuropathy and peripheral artery disease may mask these findings. Management is determined by the extent of infection and often includes oral or parenteral antibiotic therapy in combination with surgical debridement. In 2023, the International Working Group on the Diabetic Foot and the Infectious Diseases Society of America updated their guideline on the diagnosis and management of diabetic foot infection. The guideline includes specific recommendations regarding the use of inflammatory markers, tissue and bone culture, and imaging studies in the diagnosis of diabetic foot infection, as well as the indications for surgical debridement and hospitalization. Here, 2 experts in this field, an infectious diseases physician and a podiatrist, debate how to manage the case of a diabetic patient with foot infection. They discuss diagnostic and treatment challenges in the care of this population.
- 12 August 2025
- Published by American College of Physicians in Annals of Internal Medicine
How Would You Treat Tricuspid Valve Infective Endocarditis in a Patient Who Uses Injection Drugs? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Infective endocarditis is a common and morbid condition involving prolonged hospital stays, significant disability, and a high mortality rate. The current crises of injection drug use and opioid use disorder have contributed to high rates of infective endocarditis in the United States. Endocarditis in patients who inject drugs involves additional management complexity for multiple reasons. Several infective endocarditis management guidelines exist, including from the American Heart Association and the European Society of Cardiology. In light of the unique challenges of caring for this particular population, in 2022 the American Heart Association published a scientific statement specifically focusing on infective endocarditis in people who inject drugs. In these rounds, 2 experts in their respective fields, an infectious diseases specialist and a cardiac surgeon, discuss medical management, interventional approaches, and the value of multidisciplinary care for tricuspid valve endocarditis in a person who uses injection drugs, both in general and in relation to Mr. Y, a 30-year-old man with a history of substance use disorder, methicillin-sensitive Staphylococcus aureus bacteremia, and right-sided endocarditis.
- 12 August 2025
- Published by American College of Physicians in Annals of Internal Medicine
How Would You Treat Tricuspid Valve Infective Endocarditis in a Patient Who Uses Injection Drugs? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Infective endocarditis is a common and morbid condition involving prolonged hospital stays, significant disability, and a high mortality rate. The current crises of injection drug use and opioid use disorder have contributed to high rates of infective endocarditis in the United States. Endocarditis in patients who inject drugs involves additional management complexity for multiple reasons. Several infective endocarditis management guidelines exist, including from the American Heart Association and the European Society of Cardiology. In light of the unique challenges of caring for this particular population, in 2022 the American Heart Association published a scientific statement specifically focusing on infective endocarditis in people who inject drugs. In these rounds, 2 experts in their respective fields, an infectious diseases specialist and a cardiac surgeon, discuss medical management, interventional approaches, and the value of multidisciplinary care for tricuspid valve endocarditis in a person who uses injection drugs, both in general and in relation to Mr. Y, a 30-year-old man with a history of substance use disorder, methicillin-sensitive Staphylococcus aureus bacteremia, and right-sided endocarditis.
- 1 December 2024
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 177 (12) , 1695-1701
How Would You Manage This Patient With Gastroesophageal Reflux Symptoms? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Gastroesophageal reflux disease (GERD) is a common medical condition presenting with heartburn, regurgitation, cough, hoarseness, and/or wheezing. Patients with classic GERD symptoms often do not require diagnostic studies before empirical treatment is initiated. However, if atypical features are present, including alarm symptoms for malignancy, or if symptoms do not respond to conventional treatment, upper endoscopy may be necessary. The optimal management of GERD, which is the subject of debate, depends on the frequency and severity of symptoms. In 2021, the American College of Gastroenterology published updated recommendations for diagnosis and management of GERD. In addition to histamine-2 receptor antagonist or proton-pump inhibitor therapy, which may be prescribed as needed or continuously, lifestyle and dietary modification are often advised. Here, 2 physicians, a primary care practitioner and a gastroenterologist, debate how to manage a patient with GERD symptoms. They discuss the diagnosis of this condition, its initial management, indications for upper endoscopy, and how to care for the patient whose condition does not respond to empirical therapy.
- 1 December 2024
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 177 (12) , 1695-1701
How Would You Manage This Patient With Gastroesophageal Reflux Symptoms? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Gastroesophageal reflux disease (GERD) is a common medical condition presenting with heartburn, regurgitation, cough, hoarseness, and/or wheezing. Patients with classic GERD symptoms often do not require diagnostic studies before empirical treatment is initiated. However, if atypical features are present, including alarm symptoms for malignancy, or if symptoms do not respond to conventional treatment, upper endoscopy may be necessary. The optimal management of GERD, which is the subject of debate, depends on the frequency and severity of symptoms. In 2021, the American College of Gastroenterology published updated recommendations for diagnosis and management of GERD. In addition to histamine-2 receptor antagonist or proton-pump inhibitor therapy, which may be prescribed as needed or continuously, lifestyle and dietary modification are often advised. Here, 2 physicians, a primary care practitioner and a gastroenterologist, debate how to manage a patient with GERD symptoms. They discuss the diagnosis of this condition, its initial management, indications for upper endoscopy, and how to care for the patient whose condition does not respond to empirical therapy.
- 1 February 2024
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 177 (2) , 238-245
How Would You Prevent Subsequent Strokes in This Patient? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Stroke remains a major cause of morbidity, mortality, and disability, and having one stroke puts patients at risk for further strokes. The American Heart Association/American Stroke Association guidelines on secondary stroke prevention provide the basis for a discussion between 2 experts about monitoring for further stroke in a patient, as well as determining the best therapeutic strategy.
- 1 February 2024
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 177 (2) , 238-245
How Would You Prevent Subsequent Strokes in This Patient? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Stroke remains a major cause of morbidity, mortality, and disability, and having one stroke puts patients at risk for further strokes. The American Heart Association/American Stroke Association guidelines on secondary stroke prevention provide the basis for a discussion between 2 experts about monitoring for further stroke in a patient, as well as determining the best therapeutic strategy.
- 1 December 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (12) , 1656-1665
How Would You Manage This Patient With Heart Failure With Preserved Ejection Fraction?
The proportion of patients with new-onset heart failure who have preserved rather than reduced left ventricular ejection fraction (HFpEF and HFrEF) has been increasing over recent decades. In fact, HFpEF now outweighs HFrEF as the predominant heart failure subtype and likely remains underdiagnosed in the community. This is due in part to an aging population and a rise in other risk factors for HFpEF, including obesity and associated cardiometabolic disease. Whereas the diagnosis of HFrEF is relatively straightforward, the diagnosis of HFpEF is often more challenging because there can be other causes for symptoms, including dyspnea and fatigue, and cardinal physical examination findings of elevated jugular venous pressure or pulmonary congestion may not be evident at rest. In 2022, the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America published a comprehensive guideline on heart failure that included recommendations for the management of HFpEF. The use of diuretics for the management of congestion remained the only class 1 (strong) recommendation. New recommendations included broader use of sodium-glucose cotransporter-2 inhibitors (SGLT2i, class 2a), and angiotensin receptor-neprilysin inhibitors (class 2b). In 2023, the American College of Cardiology published an expert consensus decision pathway for the management of HFpEF that suggests treatment strategies based on sex assigned at birth, ejection fraction, clinical evidence of congestion, and candidacy for SGLT2i therapy. Here, 2 experts, a cardiologist and a geriatrician, discuss their approach to the diagnosis and management of HFpEF and how they would apply guidelines to an individual patient.
- 1 December 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (12) , 1656-1665
How Would You Manage This Patient With Heart Failure With Preserved Ejection Fraction?
The proportion of patients with new-onset heart failure who have preserved rather than reduced left ventricular ejection fraction (HFpEF and HFrEF) has been increasing over recent decades. In fact, HFpEF now outweighs HFrEF as the predominant heart failure subtype and likely remains underdiagnosed in the community. This is due in part to an aging population and a rise in other risk factors for HFpEF, including obesity and associated cardiometabolic disease. Whereas the diagnosis of HFrEF is relatively straightforward, the diagnosis of HFpEF is often more challenging because there can be other causes for symptoms, including dyspnea and fatigue, and cardinal physical examination findings of elevated jugular venous pressure or pulmonary congestion may not be evident at rest. In 2022, the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America published a comprehensive guideline on heart failure that included recommendations for the management of HFpEF. The use of diuretics for the management of congestion remained the only class 1 (strong) recommendation. New recommendations included broader use of sodium-glucose cotransporter-2 inhibitors (SGLT2i, class 2a), and angiotensin receptor-neprilysin inhibitors (class 2b). In 2023, the American College of Cardiology published an expert consensus decision pathway for the management of HFpEF that suggests treatment strategies based on sex assigned at birth, ejection fraction, clinical evidence of congestion, and candidacy for SGLT2i therapy. Here, 2 experts, a cardiologist and a geriatrician, discuss their approach to the diagnosis and management of HFpEF and how they would apply guidelines to an individual patient.
- 1 February 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (2) , 253-259
How Would You Resuscitate This Patient With Septic Shock?
Sepsis is a potentially life-threatening systemic dysregulatory response to infection, and septic shock occurs when sepsis leads to systemic vasodilation and subsequent tissue hypoperfusion. The Surviving Sepsis Campaign published updated guidelines in 2021 on the management of sepsis and septic shock. Here, in the context of a patient with septic shock, 2 critical care specialists discuss and debate conditional guideline recommendations on using lactate to guide resuscitation, the use of balanced crystalloids versus normal saline, and the use of corticosteroids.
- 1 February 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (2) , 253-259
How Would You Resuscitate This Patient With Septic Shock?
Sepsis is a potentially life-threatening systemic dysregulatory response to infection, and septic shock occurs when sepsis leads to systemic vasodilation and subsequent tissue hypoperfusion. The Surviving Sepsis Campaign published updated guidelines in 2021 on the management of sepsis and septic shock. Here, in the context of a patient with septic shock, 2 critical care specialists discuss and debate conditional guideline recommendations on using lactate to guide resuscitation, the use of balanced crystalloids versus normal saline, and the use of corticosteroids.
- 9 August 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (8) , 1161-+
How Would You Treat This Patient With Pulmonary Embolism?
The American Society of Hematology's 2020 updated guidelines on treatment for venous thromboembolism offer many conditional recommendations, particularly in cases of patients with transient risk fa... Pulmonary embolism can be acutely life-threatening and is associated with long-term consequences such as recurrent venous thromboembolism and chronic thromboembolic pulmonary hypertension. In 2020,...
- 9 August 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (8) , 1161-+
How Would You Treat This Patient With Pulmonary Embolism?
The American Society of Hematology's 2020 updated guidelines on treatment for venous thromboembolism offer many conditional recommendations, particularly in cases of patients with transient risk fa... Pulmonary embolism can be acutely life-threatening and is associated with long-term consequences such as recurrent venous thromboembolism and chronic thromboembolic pulmonary hypertension. In 2020,...
- 1 February 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (2) , 267-+
When and How Would You Screen This Patient for Cervical Cancer? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Successful screening programs based on cervical cytology have dramatically reduced the incidence of cervical cancer in the United States. Human papillomavirus immunization is poised to reduce it further as an increasing percentage of vaccinated women reach adulthood. A recent guideline from the American Cancer Society advises that cervical cancer screening begin at age 25 and that high-risk human papillomavirus testing is the preferred screening test. The U.S. Preventive Services Task Force recommends screening begin at age 21 and that cytology remain incorporated into screening. Here, 2 experts debate how to apply these guidelines to Ms. L, a 22-year-old woman who has never undergone cervical cancer screening.
- 1 February 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (2) , 267-+
When and How Would You Screen This Patient for Cervical Cancer? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Successful screening programs based on cervical cytology have dramatically reduced the incidence of cervical cancer in the United States. Human papillomavirus immunization is poised to reduce it further as an increasing percentage of vaccinated women reach adulthood. A recent guideline from the American Cancer Society advises that cervical cancer screening begin at age 25 and that high-risk human papillomavirus testing is the preferred screening test. The U.S. Preventive Services Task Force recommends screening begin at age 21 and that cytology remain incorporated into screening. Here, 2 experts debate how to apply these guidelines to Ms. L, a 22-year-old woman who has never undergone cervical cancer screening.
- 1 December 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (12) , 1719-1726
How Would You Treat This Patient Hospitalized With Community-Acquired Pneumonia?
Management of community-acquired pneumonia (CAP) is a topic of importance to internists. Assessing disease severity, choosing appropriate antibiotics, and deciding whether to use adjunctive cortico... Community-acquired pneumonia is a major cause of morbidity and mortality in the United States, leading to 1.5 million hospitalizations and at least 200 000 deaths annually. The 2019 American Thorac...
- 1 December 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (12) , 1719-1726
How Would You Treat This Patient Hospitalized With Community-Acquired Pneumonia?
Management of community-acquired pneumonia (CAP) is a topic of importance to internists. Assessing disease severity, choosing appropriate antibiotics, and deciding whether to use adjunctive cortico... Community-acquired pneumonia is a major cause of morbidity and mortality in the United States, leading to 1.5 million hospitalizations and at least 200 000 deaths annually. The 2019 American Thorac...
- 14 January 2020
- Published by American Medical Association (AMA) in JAMA
- Vol. 323 (2) , 125-126
Opportunities and Challenges in Valuing and Evaluating Aging Physicians
In 2017, more than 15% of practicing physicians were older than 65 years. Without a national mandatory retirement age, many physicians plan to practice until th
- 14 January 2020
- Published by American Medical Association (AMA) in JAMA
- Vol. 323 (2) , 125-126
Opportunities and Challenges in Valuing and Evaluating Aging Physicians
In 2017, more than 15% of practicing physicians were older than 65 years. Without a national mandatory retirement age, many physicians plan to practice until th